Research progress on screening prostate cancer in the PSA"gray zone"and PI-RADS 3 lesions
MA You
YANG Cheng
Abstract：Prostate cancer is a common tumor of the male genitourinary system,with its incidence continuously increasing.Early accurate diagnosis is crucial for treatment and prognosis.PSA and MRI are important methods for screening and diagnosis of prostate cancer.However,there is still controversy over whether patients with PSA levels between 4-10 μg/L and PI-RADS score of 3 need to undergo prostate biopsy.Radiomics technology provides a new approach for the early and accurate diagnosis of prostate cancer by min-ing and analyzing medical image information in a high throughput,which helps to reduce unnecessary biopsies.This article reviews the research progress of MRI radiomics in the screening of prostate cancer in the"gray zone"of PSA and PI-RADS score of 3,aiming to improve diagnostic accuracy and provide references for future research in the field of radiomics.
Keywords：prostate cancerradiomicsprostate specific antigenPI-RADS 3 lesionsmagnetic resonance imaging
Publication Date：2025-06-20
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 547-551 )